Use of the Cystic Fibrosis Foundation's extensive sputum-culturing protocol for patients without cystic fibrosis: Implications for infection control and antimicrobial resistance

American Journal of Infection Control

Volumn 42, Issue 5, 2014, Pages 546-547

  Brown, Jennifer ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antimicrobial prescribing; Bronchiectasis; Respiratory tract specimens; Sputum cultures

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PROTOCOL; CYSTIC FIBROSIS; HEALTH CARE SURVEY; HUMAN; INFECTION CONTROL; LUNG TRANSPLANTATION; NORMAL HUMAN; PULMONOLOGIST; SPUTUM CULTURE; BACTERIA; CLASSIFICATION; DRUG EFFECTS; INFORMATION PROCESSING; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES; SPUTUM; UNITED STATES;

BACTERIA; DATA COLLECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; INFECTION CONTROL; SPUTUM; UNITED STATES;

EID: 84899524366     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2014.01.004     Document Type: Article

References (11)

1. L. Saiman, and J. Seigel Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission Infect Control Hosp Epidemiol 24 2003 S6 52
2. M.A. Martínez-García, J.J. Soler-Cataluña, M. Perpiñá-Tordera, P. Román-Sánchez, and J. Soriano Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis Chest 132 2007 1565 1572
3. D. Bilton Update on non-cystic fibrosis bronchiectasis Curr Opin Pulm Med 14 2008 595 599
4. M.C. Pasteur, D. Bilton, and A.T. Hill British Thoracic Society guideline for non-CF bronchiectasis Thorax 65 Suppl 1 2010 i1 58
5. G.B. Rogers, C.J. van der Gast, L. Cuthbertson, S.K. Thomson, K.D. Bruce, and M.L. Martin et al. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition Thorax 68 2013 731 737
6. M.I. Gillham, S. Sundaram, C.R. Laughton, C.S. Haworth, D. Bilton, and J.E. Foweraker Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis J Antimicrob Chemother 63 2009 728 732
7. A.E. Seitz, K.N. Olivier, C.A. Steiner, R. Montes de Oca, S.M. Holland, and D.R. Prevots Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006 Chest 138 2010 944 949
8. D.J. Evans, A.I. Bara, and M. Greenstone Prolonged antibiotics for purulent bronchiectasis in children and adults Cochrane Database Syst Rev 2007 CD001392
9. J. Emerson, S. McNamara, A.M. Buccat, K. Worrell, and J.L. Burns Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008 Pediatr Pulmonol 45 2010 363 370
10. A.L. Smith, S.B. Fiel, N. Mayer-Hamblett, B. Ramsey, and J.L. Burns Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis Chest 123 2003 1495 1502
11. J. Zhou, E. Garber, M. Desai, and L. Saiman Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis J Clin Microbiol 44 2006 1547 1549